web analytics
10.4 C
Munich
Monday, October 25, 2021

ProText Mobility, Inc. (OTCMKTS: TXTM) Powerful Runner as Co Goes Pink Current & Massive JV with RSAMMD Gains Traction

ProText Mobility, Inc. (OTCMKTS: TXTM) is moving northbound with power in recent days quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation TXTM is moving steadily northbound with many new investors buying in every day. The stock has history of explosive moves running to $0.008 highs earlier this year. TXTM is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over $0.008 and its blue skies ahead. 

There is a lot to get excited about on TXTM which just got all the filings up to date and is now “pink current. TXTM has a Joint Venture (JV) partnership with RSAMMD to test and commercialize medical grade cannabis products using TXTM’s proprietary extraction technology from live cannabis and hemp plants. RSAMMD which owns a 20 square mile Hemp farm, one of the biggest in th world recent tweets have been very optimistic and ambitious – calling for multiple MMJ off-takes and one of the largest cannabis operations in the world. TXTM management has not been working hard behind the scenes to bring the Company current (which was just achieved) and Investors are expecting a significant merger to drop any day. 

Jobs with Protext Pharma (Formerly Knownly as Protext Mobility)ProText Mobility, Inc. (OTCMKTS: TXTM) operating out of Aventura, Florida operates a number of wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Plandai Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Phytofare Catechin Complex, has been clinically shown to have 10x greater bioavailability over generic catechin extracts. Cannabis Biosciences has developed a proprietary processing and extraction technology that utilizes live plant for producing a full-profile cannabis extract, that contains the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company has conducted in investigations in SA which has shown that the Cannabis Biosciences extraction process, using live plant material and low temperatures to extract the phyto-chemicals, leaves the acid forms of THC intact. 

TXTM has a Joint Venture (JV) partnership with RSAMMD to test and commercialize medical grade cannabis products using TXTM’s proprietary extraction technology from live cannabis and hemp plants. This extraction technology is said to improve absorption and bioavailability of the product up to 15x. They have been working together for almost a year now. Lab testing of samples has been completed and it looks like they are slowly ramping up production and finally in the position to bring a product to market. See below for details. RSAMMD’s recent tweets have been very optimistic and ambitious – calling for multiple MMJ off-takes and one of the largest cannabis operations in the world. 

https://twitter.com/chiefs5858/status/1410400473119707137

To Find out the inside Scoop on TXTM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

TXTM

Under the terms of the agreement of the JV, the JV will (i) test Protext’s proprietary extraction technology using live cannabis and hemp plants, and (ii) commercialize the resultant cannabis and hemp-based extracts. Prior human clinical trials have shown Protext’s licensed extraction technology to be effective at significantly improving absorption rates and bioavailability, as well as delivering the full phytonutrient spectrum. In exchange for covering all the costs associated with testing and commercialization, RSAMMD will receive an exclusive global license to the technology for hemp and cannabis extracts, excluding North America. Under the agreement, several live plant extraction tests will be conducted using water temperatures ranging from 55 degrees Celsius up to 95 degrees Celsius. The various tests will use live cannabis flower and leaf, and industrial hemp flower and leaf, rendered into liquid emulsions using proprietary sonoluminescence extraction technology, then sent for validation by an approved third-party lab. The lab will prepare a full chemical profile and, importantly, test the cannabis extract for psych activity (THC). 

The first phase of the agreement took place at a government-licensed facility in New Castle, SA under the supervision of Dr. Ahmed Jamaloodeen, National Treasurer of the Cannabis Development Council of South Africa (CDCSA) and property owner of the 5000 Hectare Hemp farm in New Castle where the live plants were sourced, freshly cut and provided for by RSAMMD under the agreement. His wife, Dr. Regina Hurley was also on site. Dr. Hurley, is an American Board Certified Anesthesiologist, Fellowship American Pediatric Cardiac Anesthesiologist and a well known medical cannabis Activist and advocate for CBD. She is one of a handful of practitioners who advocate the use of medical marijuana for medical purposes in South Africa and is a registered physician with the American Medical Marijuana Physicians Association. 

https://twitter.com/Jude_11/status/1422667903669841922

Fore More on TXTM Subscribe Right Now!

ProText Mobility is moving northbound with power in recent days quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation TXTM is moving steadily northbound with many new investors buying in every day. The stock has history of explosive moves running to $0.008 highs earlier this year. TXTM is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – a break over $0.008 and its blue skies ahead. There is a lot to get excited about on TXTM which just got all the filings up to date and is now “pink current. TXTM has a Joint Venture (JV) partnership with RSAMMD to test and commercialize medical grade cannabis products using TXTM’s proprietary extraction technology from live cannabis and hemp plants. RSAMMD which owns a 20 square mile Hemp farm, one of the biggest in th world recent tweets have been very optimistic and ambitious – calling for multiple MMJ off-takes and one of the largest cannabis operations in the world. TXTM management has not been working hard behind the scenes to bring the Company current (which was just achieved) and Investors are expecting a significant merger to drop any day. We will be updating on TXTM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TXTM.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in TXTM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.